CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response

Blood Adv. 2023 Oct 10;7(19):5937-5940. doi: 10.1182/bloodadvances.2023010127.
No abstract available

MeSH terms

  • Aged
  • Antigens, CD19
  • Humans
  • Immunotherapy, Adoptive*
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Transplantation, Autologous

Substances

  • Antigens, CD19